-+ 0.00%
-+ 0.00%
-+ 0.00%

PRELUDE THERAPEUTICS INCORPORATED : JP MORGAN INITIATES COVERAGE WITH OVERWEIGHT RATING; PRICE TARGET $12

路透·09/17/2026 04:21:44

登录查看新闻详情